Alliance for Lupus Research (ALR): Target Identification in Lupus (TIL) - Letter of Intent

The purpose of TIL is to fund innovative research focused on the identification and scientific and/or clinical advancement of therapeutic targets, that will lead to new therapies for the treatment of lupus. The goals of this program are to: (1) characterize key steps in the pathogenesis of the disease that will allow for the development of new therapeutic agents; (2) promote basic and clinical research studies to identify and/or better characterize promising lead compounds for lupus treatment; and (3) support research that facilitates the clinical evaluation of innovative approaches to the prevention or treatment of lupus and its complications. As the goal of this program is to advance the treatment of lupus, any research funded must be based on realizable goals for translation into therapeutic discovery programs. Targets can include small molecules, biologic agents, vaccines, gene therapy, as well as novel approaches in public health and risk reduction. Funding: up to $600,000 over 3 years.

http://www.lupusresearch.org/lupus-research/for-researchers.html#.U5DpkSjF6Nk